|
TLR6与MyD88在小鼠肥胖发生过程中的作用机制研究
|
Abstract:
目的:探究Toll样受体6 (TLR6)和髓样分化因子88 (MyD88)在肥胖发生发展中发挥的作用。方法:C57BL/6J雄性小鼠20只,随机分为对照组和模型组。对照组给予普通饲料喂养,模型组给予高脂饲料喂养。12周后称重并提取小鼠腹股沟脂肪组织;Western blot检测各组小鼠脂肪组织中TLR6、髓样分化因子88 (MyD88)蛋白表达。结果:肥胖小鼠腹肌沟脂肪组织切片显示脂肪细胞数量增多,间质内可见多量巨噬细胞,TLR6和Myd88蛋白在肥胖小鼠脂肪组织中表达增加。结论:TLR6及Myd88可能通过升高脂肪组织的炎症水平参与了小鼠肥胖的发生。
Objective: To investigate the roles played by Toll-like receptor 6 (TLR6) and myeloid differentiation factor 88 (MyD88) in the development of obesity. Methods: Twenty C57BL/6J male mice were ran-domly divided into control and model groups. The control group was fed standard chow, and the model group was fed high-fat food. Twelve weeks later, the inguinal adipose tissues of the mice were weighed and extracted; the expression of TLR6 and MyD88 in the fatty tissues of each group was detected by Western blot. Results: Groin adipose tissue sections of obese mice showed an increase in the number of adipocytes and a high number of macrophages in the interstitium and increased expression of TLR6 and Myd88 proteins in the adipose tissue of obese mice. Conclusion: TLR6 and Myd88 may be involved in developing obesity in mice by elevating the level of inflammation in adi-pose tissue.
[1] | Mi, S., et al. (2019) Expression of TLR4/MyD88/NF-κB Pathway Genes and Its Related Inflammatory Factors in Secondary Spinal Cord Injury. Journal of Zhejiang University. Medical Sciences, 48, 609-616. |
[2] | Sindhu, S., Thomas, R., Shihab, P., Sriraman, D., Behbehani, K. and Ahmad, R. (2015) Obesity Is a Positive Modulator of IL-6R and IL-6 Expression in the Subcutaneous Adipose Tissue: Significance for Metabolic Inflammation. PLOS ONE, 10, e0133494. https://doi.org/10.1371/journal.pone.0133494 |
[3] | Panuganti, K.K., Nguyen, M. and Kshirsagar, R.K. (2023) Obesity. StatPearls Publishing Copyright, Treasure Is-land. |
[4] | World Health Organization (2014) Global Status Report on Noncommunicable Diseases 2014. World Health Organization, Geneva. |
[5] | Conway, B. and Rene, A. (2004) Obesity as a Disease: No Lightweight Matter. Obesity Re-views, 5, 145-151.
https://doi.org/10.1111/j.1467-789X.2004.00144.x |
[6] | St?pień, M., St?pień, A., Wlaze?, R.N., Paradowski, M., Banach, M. and Rysz, J. (2014) Obesity Indices and Inflammatory Markers in Obese Non-Diabetic Normo- and Hyper-tensive Patients: A Comparative Pilot Study. Lipids in Health and Disease, 13, Article No. 29. https://doi.org/10.1186/1476-511X-13-29 |
[7] | 司原成, 苗维纳, 何嘉悦, 等. 肥胖-肠道菌群-Toll样受体交互调控作用的研究进展[J]. 世界华人消化杂志, 2016, 24(15): 2361-2367. |
[8] | Arias-Loste, M.T., et al. (2016) In-creased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Mor-bidly Obese Patients with Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences, 17, 1878. https://doi.org/10.3390/ijms17111878 |
[9] | 张梦捷, 孙爱平, 李慧, 等. Toll样受体与肥胖[J]. 中国免疫学杂志, 2018, 34(9): 1428. |
[10] | Miura, K., Ishioka, M. and Iijima, K. (2017) The Roles of the Gut Microbiota and Toll-Like Receptors in Obesity and Nonalcoholic Fatty Liver Disease. Journal of Obesity & Metabolic Syndrome, 26, 86-96.
https://doi.org/10.7570/jomes.2017.26.2.86 |
[11] | Chen, L., Zheng, L.L., Chen, P.Q. and Liang, G. (2020) Myeloid Differentiation Primary Response Protein 88 (MyD88): The Central Hub of TLR/IL-1R Signaling. Journal of Medicinal Chemistry, 63, 13316-13329.
https://doi.org/10.1021/acs.jmedchem.0c00884 |
[12] | Lin, X. and Li, H. (2021) Obesity: Epidemiology, Pathophysi-ology, and Therapeutics. Frontiers in Endocrinology (Lausanne), 12, Article ID: 706978. https://doi.org/10.3389/fendo.2021.706978 |
[13] | Longo, M., et al. (2019) Adipose Tissue Dysfunction as Determi-nant of Obesity-Associated Metabolic Complications. International Journal of Molecular Sciences, 20, 2358. https://doi.org/10.3390/ijms20092358 |
[14] | Engin, A. (2017) The Pathogenesis of Obesity-Associated Adipose Tissue Inflammation. Advances in Experimental Medicine and Biology, 960, 221-245. https://doi.org/10.1007/978-3-319-48382-5_9 |
[15] | Tilg, H. and Moschen, A.R. (2008) Inflammatory Mechanisms in the Regulation of Insulin Resistance. Molecular Medicine, 14, 222-231. https://doi.org/10.2119/2007-00119.Tilg |
[16] | Kawai, T., Autieri, M.V. and Scalia, R. (2021) Adipose Tissue Inflammation and Metabolic Dysfunction in Obesity. American Journal of Physiology-Cell Physiology, 320, C375-C391. https://doi.org/10.1152/ajpcell.00379.2020 |
[17] | Ellulu, M.S., Patimah, I., Khaza’ai, H., Rahmat, A. and Abed, Y. (2017) Obesity and Inflammation: The Linking Mechanism and the Complications. Archives of Medical Science, 13, 851-863. https://doi.org/10.5114/aoms.2016.58928 |